Cutler Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$10K Sell
1,400
-600
-30% -$4.29K ﹤0.01% 627
2023
Q4
$17K Sell
2,000
-700
-26% -$5.95K ﹤0.01% 887
2023
Q3
$24K Buy
2,700
+700
+35% +$6.22K ﹤0.01% 842
2023
Q2
$30K Hold
2,000
﹤0.01% 729
2023
Q1
$44K Hold
2,000
﹤0.01% 664
2022
Q4
$42K Hold
2,000
﹤0.01% 869
2022
Q3
$49K Hold
2,000
﹤0.01% 899
2022
Q2
$48K Buy
+2,000
New +$48K ﹤0.01% 897
2022
Q1
Hold
0
2575
2021
Q4
Hold
0
2630
2021
Q3
Hold
0
2733
2020
Q4
Sell
-800
Closed -$14K 2376
2020
Q3
$14K Sell
800
-800
-50% -$14K ﹤0.01% 1239
2020
Q2
$32K Sell
1,600
-4,100
-72% -$82K ﹤0.01% 978
2020
Q1
$83K Sell
5,700
-200
-3% -$2.91K ﹤0.01% 645
2019
Q4
$83K Sell
5,900
-200
-3% -$2.81K 0.01% 741
2019
Q3
$70K Buy
+6,100
New +$70K 0.01% 706
2019
Q2
Hold
0
2200
2019
Q1
Sell
-68
Closed -$1K 2193
2018
Q4
$1K Hold
68
﹤0.01% 1539
2018
Q3
$1K Sell
68
-300
-82% -$4.41K ﹤0.01% 1543
2018
Q2
$10K Buy
368
+300
+441% +$8.15K ﹤0.01% 1307
2018
Q1
$1K Sell
68
-932
-93% -$13.7K ﹤0.01% 1716
2017
Q4
$21K Sell
1,000
-400
-29% -$8.4K ﹤0.01% 1376
2017
Q3
$34K Sell
1,400
-4,690
-77% -$114K ﹤0.01% 1442
2017
Q2
$118K Sell
6,090
-200
-3% -$3.88K ﹤0.01% 1112
2017
Q1
$116K Sell
6,290
-5,810
-48% -$107K ﹤0.01% 1062
2016
Q4
$229K Buy
12,100
+11,900
+5,950% +$225K 0.01% 796
2016
Q3
$4K Sell
200
-8,483
-98% -$170K ﹤0.01% 2448
2016
Q2
$154K Buy
8,683
+214
+3% +$3.8K 0.01% 809
2016
Q1
$115K Sell
8,469
-16,569
-66% -$225K 0.01% 864
2015
Q4
$482K Buy
+25,038
New +$482K 0.03% 394